
Byron Austin
Sustainability Executive
Byron is a corporate sustainability executive who specializes in the life sciences industry. In his most recent role, he led corporate responsibility and environmental, social and governance (ESG) management at Organon, a pharma company focused on the health of women, where he was responsible for supporting the development and implementation of the company’s ESG strategy while also overseeing global philanthropy.
Prior to Organon, Byron led ESG communications at Teva Pharmaceuticals, where he also had responsibility for the company's corporate social responsibility efforts in the United States and Canada while supporting the company's global health and access strategy around the world. Before joining Teva, Byron led the healthcare practice at Business for Social Responsibility (BSR), a global business network and consultancy focused on building the capacity of large companies to become more sustainable and socially responsible. At BSR, he advised over 25 companies in the biopharmaceutical and medical device industry on their ESG and sustainability strategies. Prior to BSR, Byron managed and developed global health partnerships at Johnson & Johnson, where he engaged a variety of stakeholders in the fields of NCDs, HIV/AIDS, maternal and child health, and digital health.
Byron began his career in global health at an HIV/AIDS NGO based in South Africa called mothers2mothers International and later served as a management consultant at Rabin Martin in New York City.
Byron earned his MBA from Columbia Business School and his BA from Princeton University.
Prior to Organon, Byron led ESG communications at Teva Pharmaceuticals, where he also had responsibility for the company's corporate social responsibility efforts in the United States and Canada while supporting the company's global health and access strategy around the world. Before joining Teva, Byron led the healthcare practice at Business for Social Responsibility (BSR), a global business network and consultancy focused on building the capacity of large companies to become more sustainable and socially responsible. At BSR, he advised over 25 companies in the biopharmaceutical and medical device industry on their ESG and sustainability strategies. Prior to BSR, Byron managed and developed global health partnerships at Johnson & Johnson, where he engaged a variety of stakeholders in the fields of NCDs, HIV/AIDS, maternal and child health, and digital health.
Byron began his career in global health at an HIV/AIDS NGO based in South Africa called mothers2mothers International and later served as a management consultant at Rabin Martin in New York City.
Byron earned his MBA from Columbia Business School and his BA from Princeton University.